Active, not recruiting
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
NCT04725994
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
- Locations
-
- USC Norris Comp. Cancer Ctr Hospital Los Angeles, California, United States
- Hematology Oncology Clinic Baton Rouge / Sarah Cannon Baton Rouge, Louisiana, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States